HIV
News
AAP approves CDC’s child/adolescent vax schedule for 2022
A new vaccine has been added to the schedule.
Conference Coverage
16 toddlers with HIV at birth had no detectable virus 2 years later
“We’re confirming here that the first step toward remission and cure is reducing reservoirs. We’ve got that here.”
Conference Coverage
A third person living with HIV has been cured by transplant
“There was no GVH disease. That’s incredible. It’s a wonderful thing.”
Latest News
Highly virulent HIV variant discovered in the Netherlands
Discovery of the VB variant provides “a rare example of the risk posed by viral virulence evolution.”
News
FDA approves 2-month dosing of injectable HIV drug Cabenuva
“Adults living with HIV have a treatment option that further reduces the frequency of medication,” said Candice Long of Janssen Therapeutics.
Latest News
HIV stigma persists globally, according to Harris poll
Pervasive stereotypes and stigmatization only serve to magnify preexisting social inequities that affect access to appropriate care.
Latest News
Moderna launches clinical trials for HIV vaccine
The vaccine is designed to prompt white blood cells to turn into antibodies that can neutralize HIV.
Latest News
Dapivirine vaginal ring for HIV prevention no longer under consideration by the FDA
That leaves cisgender women – especially the Black and Latinx women who make up the vast majority of women who acquire HIV every year – with two...
From the Journals
Clinician experience, life stressors drive HIV adherence, retention in new patients
“Patients who reported better initial experiences with their provider at the first visit were less likely to be lost to follow-up,” said Dr....
From the Journals
HIV+ patients get good outcomes after kidney or liver transplant
New research further supports the inclusion of people with HIV in transplant resource allocation.
From the Journals
Antiretroviral pill better at suppressing HIV in children
The pill-based regimen reduced the chances of treatment failure among children aged 3-18 by about 40%, compared with other treatments.